Biotech · Private company
Clarus Therapeutics, Inc.
Track this companyFree. Adds Clarus Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Oral testosterone undecanoatePhase 3 · Male HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Transdermal testosterone gel (AndroGel)Phase 3 · Male HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Oral testosterone undecanoate (containing 300 mg T)Phase 2 · Male HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Oral testosterone undecanoate (TU) (200 mg T equivalents/dose with and without food)Phase 2 · HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Oral testosterone undecanoate (TU) (300 mg T equivalents/dose)Phase 2 · HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Oral testosterone undecanoate (TU) combined with testosterone enanthate (TE) (300 mg T equivalents/dose)Phase 2 · HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Oral testosterone undecanoate (TU) combined with testosterone enanthate (TE) (400 mg T equivalents/dose)Phase 2 · HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Testosterone undecanoatePhase 2 · Male HypogonadismClinicalTrials.gov · fetched Nov 12, 2026
- Testosterone UndecanoatePhase 1 · Hypogonadism, MaleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Testosterone Treatment in Men With Chronic Kidney DiseasePHASE2 · RECRUITING · started Mar 15, 2022ClinicalTrials.gov NCT05249634 · fetched Nov 12, 2026
- Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 7, 2022ClinicalTrials.gov NCT05081193 · fetched Nov 12, 2026
- Patient Satisfaction After Switching to Oral Testosterone UndecanoatePHASE4 · COMPLETED · started Jun 18, 2021ClinicalTrials.gov NCT04983940 · fetched Nov 12, 2026
- Assessment of Blood From Men Receiving Oral TU in Various Collection TubesPHASE1 · COMPLETED · started Jul 15, 2018ClinicalTrials.gov NCT03973840 · fetched Nov 12, 2026
- Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal MenPHASE3 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01699178 · fetched Nov 12, 2026
- Pharmacokinetic Study to Determine Time to Steady-statePHASE2 · COMPLETED · started Jul 1, 2009ClinicalTrials.gov NCT00911586 · fetched Nov 12, 2026
- Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate FormulationPHASE2 · COMPLETED · started Jul 1, 2009ClinicalTrials.gov NCT00924612 · fetched Nov 12, 2026
- Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal MenPHASE2 · COMPLETED · started Jun 1, 2008ClinicalTrials.gov NCT00695110 · fetched Nov 12, 2026